Avid Bioservices Appoints Dave Stewart as Chief Technology and Transformation Officer to Drive Growth Avid Bioservices has named Dave Stewart as its Chief Technology and Transformation Officer, enhancing its commitment to innovation and growth in biologics manufacturing.

Avid Bioservices Appoints Dave Stewart as Chief Technology and Transformation Officer to Drive Growth #USA #Avid_Bioservices #Tustin,_California #Biologics_CDMO #Dave_Stewart

Zydus Lifesciences Expands into Global Biologics CDMO Market Through Acquisition of Agenus Facilities Zydus Lifesciences is making a strategic move into the biologics CDMO sector, aiming to acquire Agenus' U.S. manufacturing facilities to enhance innovative therapy development.

Zydus Lifesciences Expands into Global Biologics CDMO Market Through Acquisition of Agenus Facilities #India #Ahmedabad #Biologics_CDMO #Zydus_Lifesciences #Agenus

AI-Driven Growth: The Rise of the Biologics CDMO Market Forecast by Technavio The global biologics CDMO market is expected to increase by USD 16.32 billion from 2025 to 2029, driven by AI advancements and emerging market resources.

AI-Driven Growth: The Rise of the Biologics CDMO Market Forecast by Technavio #USA #New_York #Technavio #AI_Trends #Biologics_CDMO

Anticipating Growth in the Global Biologics CDMO Market by 2029 The global CDMO market for biologics is set to expand significantly, projected to increase by $16.32 billion between 2025 and 2029, driven by advancements in technology.

Anticipating Growth in the Global Biologics CDMO Market by 2029 #USA #New_York #Market_Growth #Technavio #Biologics_CDMO

Biologics CDMO Market Predicted to Expand Significantly with AI Innovations Driving Growth The global biologics CDMO market is expected to grow by USD 10.63 billion from 2024 to 2028, driven by AI advancements and cost-effective resources.

Biologics CDMO Market Predicted to Expand Significantly with AI Innovations Driving Growth #United_States #New_York #Market_Growth #AI_Innovations #Biologics_CDMO